F
MREO

F3Logic’s Mereo BioPharma MREO Stock Holding History

F3Logic’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-255
Closed -$668 – 340
2020
Q3 		$668 Buy
+255
New +$745 0.02% 316

Other funds holding MREO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

F3Logic's MREO Position: Q4 2020 in Review

F3Logic sold out of Mereo BioPharma (MREO) in Q4 2020, closing a stake of 255 shares — an estimated $668 sold.

F3Logic first reported a position in MREO in Q3 2020 and held it in 1 quarter. The position peaked at $668 in Q3 2020. 47 funds tracked by Wall St. Rank hold MREO as of Q4 2020.

  • F3Logic reported no remaining Mereo BioPharma position as of Q4 2020 after selling out during the quarter.
  • F3Logic sold 255 Mereo BioPharma shares in Q4 2020, an estimated $668.
  • F3Logic first reported a position in Mereo BioPharma in Q3 2020 and held it in 1 quarter.
  • F3Logic's Mereo BioPharma position peaked at $668 in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2020.

Based on F3Logic's 13F filing for Q4 2020, filed 12 Feb 2021.